Dublin, June 26, 2019 (GLOBE NEWSWIRE) -- The "The 2019 U.S. HIV Market: Analyses & Forecasts Through 2014-2024" report has been added to ResearchAndMarkets.com's offering.
This latest research provides comprehensive insights into HIV pipeline products, HIV epidemiology, HIV market valuations and forecast, HIV drugs sales and competitive landscape in the US.
The research is classified into seven sections- HIV treatment options, pipeline products, market analysis comprising of epidemiology, key products marketed, market valuations and forecast, drugs sales and market shares.
Benefits of this Research
Key Topics Covered
1) HIV Treatments
2) HIV Pipeline
3) US HIV Epidemiology
4) Marketed Drugs for HIV in US
5) US HIV Market Size and Forecast
6) US HIV Products Sales and Forecast
7) US HIV Market Competitive Landscape
List of Tables
1. HIV Phase 3 Clinical Trials, 2019
2. HIV Phase 2 Clinical Trials, 2019
3. HIV Phase 1 Clinical Trials, 2019
4. HIV Epidemiology, US, 2014 - 2024
5. Marketed Drugs for HIV, US, 2018
6. HIV Market Size and Forecast ($), US, 2014 - 2024
7. HIV Product Sales ($), US, 2014 - 2024
List of Figures
1. HIV Epidemiology, US, 2014 - 2024
2. HIV Market Size and Forecast ($), US, 2014 - 2024
3. HIV Products Market Share (%), US, 2018
For more information about this report visit https://www.researchandmarkets.com/r/9ftek0
Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager firstname.lastname@example.org For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 Related Topics: Infectious Diseases Drugs, HIV/AIDS Drugs